Press releases
Stay current with the latest press releases from within the industry.
- Press releases
- Probiodrug
- Probiodrug Reported on...
Probiodrug Reported on Clinical Phase IIa Trial in Diabetes
Release issued 15th December 2003
Probiodrug AG, a private biotech company headquartered in Halle, Germany, announced today its expectation to have favorable results to report on its first limited Phase IIa trial of its DP IV inhibitor, P93/01, in diabetics. The double -blind, placebo-controlled, cross-over trial, performed in Germany with 16 drug-naïve diabetes patients, showed a statistically significant (p
Company details
If you want to find out more about the company visit Probiodrug profile.
Latest Probiodrug press releases
(25th June 2007) Probiodrug AG, Halle (Saale) Acquires Ingenium Pharmaceuticals AG (Munich)
(16th June 2006) Probiodrug Closes a EUR 10.6 Million (US$ 13.4 million) Financing Round
(6th July 2004) Probiodrug awarded a €1.9mio BioChancePlus grant
(18th June 2004) Prosidion and Probiodrug conclude metabolic deal
(16th December 2003) Probiodrug hosts Scientific Advisory Board December 12th & 13th
Related reports
More Press Releases
Latest
Most viewed
- euroPLX Introduces Tool to Overcome Reject vs. Accept Dilemma in Partnering
- Genesis Conference on target to exceed all previous years
- Two papers on Neo-Penotran® Forte and Neo-Penotran® Forte-L have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004
- Discovery and validation of 13 diabetes biomarkers to be commercialized
- TDS® TESTOSTERONE EXCEEDS ANDROGEL® OUTCOMES
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us